Tag: reuters-health
-
Doctors should offer women birth control right after babies arrive
By Lisa Rapaport (Reuters Health) – Women should have the chance to get long-acting birth control like intrauterine devices (IUDs) before they leave the hospital with a new baby, a leading group of U.S. obstetricians recommends. The American College of Obstetricians and Gynecologists (ACOG) has long advocated that women have access to IUDs and contraceptive…
-
Remote heart monitoring can help detect emergencies
By Lisa Rapaport (Reuters Health) – Instead of having heart monitors with noisy alarms near patients’ beds in the hospital, it might be better to have off-site technicians do the heart monitoring remotely, a recent study suggests. Traditional on-site heart monitoring can involve a lot of false alarms that don’t always help detect cardiac arrests…
-
Timeline: Zika’s origin and global spread
The following timeline charts the origin and spread of the Zika virus from its discovery nearly 70 years ago: 1947: Scientists researching yellow fever in Uganda’s Zika Forest identify the virus in a rhesus monkey 1948: Virus recovered from Aedes africanus mosquito in Zika Forest 1952: First human cases detected in Uganda and Tanzania 1954:…
-
U.S. drugmaker Biogen’s profit beats Street; CEO to leave
(Reuters) – Biogen Inc's quarterly adjusted profit blew past Wall Street estimates on higher sales of its multiple sclerosis drugs, and the company said Chief Executive George Scangos would leave in the coming months. Shares of the company, whose board also authorized a $5 billion share repurchase program, rose about 5 percent to $276 in…
-
Theranos hires executives to lead regulatory and compliance push
(Reuters) – Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators.
-
Roche beats forecasts on new drugs and one-off gain
By Ludwig Burger BASEL, Switzerland (Reuters) – Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs…